FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX
K Number: K260770
·
Decision Jun 4, 2026
Classifications
1
FEI Numbers
25
Registration Numbers
25
Same Product Code
0
Applicant Total
71
Review Days
87
Basic Information
- Device Name
- LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX
- K Number
- K260770
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.3172
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- DiaSorin, Inc.
- Date Received
- March 9, 2026
- Decision Date
- June 4, 2026
- Product Code
- LOM
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LOM | Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) | FDA class 2 | Microbiology |
Other Clearances by DiaSorin, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| DEN250032 | LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261) | Dec 23, 2025 | Unknown |
| K231214 | LIAISON VZV IgG HT, LIAISON Control VZV IgG HT | Oct 27, 2023 | Substantially Equivalent |
| K223403 | LIAISON Anti-HAV; LIAISON XS | Dec 9, 2022 | Substantially Equivalent |
| K213858 | LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus | Jul 26, 2022 | Substantially Equivalent |
| K213936 | LIAISON MeMed BV, LIAISON MeMed BV Control Set | Jul 14, 2022 | Substantially Equivalent |
| K193650 | LIAISON Ferritin | Sep 14, 2021 | Substantially Equivalent |
| K202573 | LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody Plus | Feb 18, 2021 | Substantially Equivalent |
| K202574 | LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody Plus | Feb 18, 2021 | Substantially Equivalent |
| K210272 | LIAISON Anti-HAV | Feb 9, 2021 | Substantially Equivalent |
| K201908 | LIAISON Testosterone xt | Oct 15, 2020 | Substantially Equivalent |